var data={"title":"Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical features and diagnosis of placenta accreta spectrum (placenta accreta, increta, and percreta)</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributors\" class=\"contributor contributor_credentials\">Robert Resnik, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributors\" class=\"contributor contributor_credentials\">Robert M Silver, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributors\" class=\"contributor contributor_credentials\">Deborah Levine, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributors\" class=\"contributor contributor_credentials\">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributors\" class=\"contributor contributor_credentials\">Vanessa A Barss, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 14, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placenta accreta spectrum (PAS) is a general term used to describe placenta accreta, increta, and percreta. It results from placental implantation at an area of defective decidualization typically caused by preexisting damage to the endometrial-myometrial interface.</p><p>This topic will discuss the clinical features and diagnosis of the PAS. Management of patients with a PAS is reviewed separately. (See <a href=\"topic.htm?path=management-of-the-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">&quot;Management of the placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1822804338\"><span class=\"h1\">DEFINITIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta accreta &ndash; anchoring placental villi attach to the myometrium (rather than decidua) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta increta &ndash; anchoring placental villi penetrate into the myometrium</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta percreta &ndash; anchoring placental villi penetrate through the myometrium to the uterine serosa or adjacent organs</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">INCIDENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placenta accreta is much more common than placenta increta and percreta. In a pooled analysis of results from two series involving a total of 138 histologically confirmed, abnormally implanted placentas from hysterectomy specimens, the types and frequencies of abnormal placentation were [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/1,2\" class=\"abstract_t\">1,2</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta accreta: 79 percent </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta increta: 14 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta percreta: 7 percent</p><p/><p>In 1950, placenta accreta was rare, occurring in 1 in 30,000 deliveries in the United States (US) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/1,3\" class=\"abstract_t\">1,3</a>]. During the 1980s and 1990s, the incidence markedly increased, reaching 1 in 731 deliveries between 2008 and 2011 in a cohort of over 115,000 deliveries in 25 hospitals in the US [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The marked increase has been attributed to the increasing prevalence of cesarean delivery in recent decades. The incidence of placenta accreta in Canada was 1 in 695 deliveries in 2009 to 2010 [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"#H3937600\" class=\"local\">'Risk factors'</a> below.).</p><p class=\"headingAnchor\" id=\"H3937332\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of the PAS is not known with certainty. The most common theory is that defective decidualization (thin, poorly formed, partial, absent or dysfunctional decidua) in an area of scarring caused by previous uterine surgery allows the placenta to attach directly to or invade the myometrium [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/5,6\" class=\"abstract_t\">5,6</a>]. This theory is supported by the observation that 80 percent of these cases are associated with a history of previous cesarean delivery, curettage, <span class=\"nowrap\">and/or</span> myomectomy [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/5\" class=\"abstract_t\">5</a>]. Other theories, which may account for a proportion of cases, attribute PAS to&nbsp;excessive extravillous trophoblastic invasion or defective maternal vascular remodeling in an area of scarring [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/7\" class=\"abstract_t\">7</a>]. In rare cases, uterine pathology such as bicornuate uterus, adenomyosis, or submucous fibroids may be associated with microscopic endometrial defects that interfere with normal biological endometrial functions and thereby allow abnormal placental attachment [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/8\" class=\"abstract_t\">8</a>].</p><p>The occurrence of placenta increta and percreta may be due to partial or complete dehiscence of a uterine scar, which allows the extravillous trophoblast direct access to the deeper myometrium, serosa, and beyond [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/5\" class=\"abstract_t\">5</a>]. Large and deep myometrial defects are often associated with absence of normal reepithelialization of the scar [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/9\" class=\"abstract_t\">9</a>]. A placenta may have both adherent and invasive villi, and the depth of invasive may evolve with advancing gestation [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/8\" class=\"abstract_t\">8</a>]. However, there are confirmed cases of placenta percreta as early as 16 weeks of pregnancy, which suggests that, at least in some cases, the &quot;die is cast&quot; at implantation as to whether an accreta, increta, or percreta will develop and that increasing depth of invasion is not related to increasing duration of gestation. </p><p>The factors that regulate the extent of pathological invasion (eg, accreta versus percreta) are not well defined. (See <a href=\"topic.htm?path=placental-development-and-physiology\" class=\"medical medical_review\">&quot;Placental development and physiology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H3937600\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most important risk factor for development of a PAS is placenta previa after a prior cesarean delivery. In a prospective study including 723 women with placenta previa undergoing cesarean delivery, the frequency of PAS increased with an increasing number of cesarean deliveries as follows [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/10\" class=\"abstract_t\">10</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>First cesarean birth, 3 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Second cesarean birth, 11 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Third cesarean births, 40 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fourth cesarean births, 61 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fifth or greater cesarean birth, 67 percent</p><p/><p>In the absence of placenta previa, the frequency of a PAS in women undergoing cesarean delivery was much lower [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/10\" class=\"abstract_t\">10</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>First cesarean birth, 0.03 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Second cesarean birth, 0.2 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Third cesarean birth, 0.1 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fourth or fifth cesarean birth, 0.8 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sixth or greater cesarean birth, 4.7 percent</p><p/><p>Other risk factors include a history of uterine surgery (eg, myomectomy entering the uterine cavity, hysteroscopic removal of intrauterine adhesions, cornual resection of ectopic pregnancy, dilatation and curettage, endometrial ablation), cesarean scar pregnancy, maternal age greater than 35 years, history of pelvic irradiation, manual removal of the placenta, postpartum endometritis, and infertility <span class=\"nowrap\">and/or</span> infertility procedures (eg, in vitro fertilization) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/11-18\" class=\"abstract_t\">11-18</a>]. </p><p>Consideration of risk factors other than previous cesarean is particularly important in women having a first ongoing pregnancy. In a retrospective study limited to primiparous women with invasive placentation, the relative risk [RR] of invasive placentation for those with a history of one and two previous gynecologic procedures (including suction curettage for pregnancy termination) was 1.5 (CI 1.1-1.9) and RR 2.7 (CI 1.7-4.4), respectively [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/18\" class=\"abstract_t\">18</a>]. </p><p>It is important to note that in a multivariate analysis, placenta previa appeared to be an independent risk factor for PAS (odds ratio [OR] 54; 95% CI 18-166), while prior uterine surgery was not (OR, 1.5, 95% CI, 0.4&ndash;5.1) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Interestingly, the sex ratio associated with PAS favors females, which is opposite to the normal sex ratio in the general population, which favors males [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/20,21\" class=\"abstract_t\">20,21</a>].</p><p class=\"headingAnchor\" id=\"H3939541\"><span class=\"h2\">Clinical presentation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ideally, PAS is first suspected because of findings on obstetrical ultrasound examination while the patient is asymptomatic. It is often diagnosed during prenatal sonographic screening of women with a placenta previa or a low anterior placenta and prior uterine surgery. In women with less prominent risk factors for abnormal placental attachment, it may be an incidental finding during routine ultrasound examination. (See <a href=\"#H1042633652\" class=\"local\">'Prenatal screening and diagnosis'</a> below.)</p><p>The first clinical manifestation of PAS is usually profuse, life-threatening hemorrhage that occurs at the time of attempted manual placental separation. In contrast to a simple retained placenta, part or all of the placenta remains strongly attached to the uterine cavity, and no plane of separation can be developed. However, it also may present as antenatal bleeding in the setting of placenta previa.</p><p class=\"headingAnchor\" id=\"H260805669\"><span class=\"h2\">Possible laboratory findings</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Elevated maternal serum alpha-fetoprotein</strong> &ndash; Several series and case reports have reported an association between PAS and otherwise unexplained elevations in second trimester maternal serum alpha-fetoprotein (MSAFP) concentration (&gt;2 or 2.5 multiples of the median [MOM]) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/19,22,23\" class=\"abstract_t\">19,22,23</a>]. Although an elevated MSAFP level supports an ultrasound-based diagnosis of abnormal placental implantation, it is an inconsistent finding and is not useful by itself for diagnosis. Moreover, a normal MSAFP does not exclude the diagnosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hematuria</strong> &ndash; Placenta percreta with bladder invasion can cause hematuria during pregnancy. A literature review including 54 cases of placenta percreta invading the bladder reported that <span class=\"nowrap\">17/54</span> were associated with hematuria [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/24\" class=\"abstract_t\">24</a>]. Cystoscopy was performed in 12 patients but was not useful for making a preoperative diagnosis. This may be due to microscopic invasion of the bladder that is not visible on cystoscopy but can lead to hematuria. </p><p/><p class=\"headingAnchor\" id=\"H15006491\"><span class=\"h2\">Consequences</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When removal of the placenta is attempted after delivery, the lack of a normal plane of cleavage between the placental basal plate and the uterine wall results in major hemorrhage. The severity of hemorrhage is especially severe with more invasive placentation because of hypervascularity of the placental bed (local neovascularization and vasodilatation) and is a common indication for peripartum hysterectomy [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/4,25,26\" class=\"abstract_t\">4,25,26</a>]. Additional potential sequelae of massive hemorrhage include disseminated intravascular coagulopathy, adult respiratory distress syndrome, renal failure, unplanned surgery, and death.</p><p>Information on neonatal outcome in pregnancies complicated by PAS is limited. One case-control study including 310 patients reported a significant increase in preterm birth (11 versus 1 percent in controls) and small for gestational age infants (27 versus 14 percent in controls) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/27\" class=\"abstract_t\">27</a>]. Neonatal outcome does not appear to be significantly affected by depth of placental invasion (accreta versus percreta) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/28\" class=\"abstract_t\">28</a>] but is strongly related to gestational age at delivery.</p><p>In contrast, adverse maternal outcome may increase with placenta percreta versus accreta since extrauterine anatomic structures, including blood vessels in the pelvis, may be invaded by the placenta and complicate hysterectomy. If an accreta rather than a percreta was suspected before delivery, preoperative preparation for delivery may be inadequate. The integrity of the previous hysterotomy scar may be compromised by a percreta, predisposing to uterine rupture. A review including 109 cases of placenta percreta reported the following types and frequencies of complications: transfusion of over 10 units (44 cases), infection (31 cases), maternal death (8 cases), ureteral ligation or fistula formation (5 cases each), and spontaneous uterine rupture (3 cases) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/29\" class=\"abstract_t\">29</a>]. These cases were derived from a questionnaire issued to members of the Society for Maternal-Fetal Medicine and a retrospective study at one institution; therefore, the complication rates may be higher than those that would be observed from a prospective consecutive series.</p><p>Maternal and perinatal death are uncommon in case series from tertiary care centers where multispecialty expertise is usually available; however, these reports are prone to selection bias [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/30-32\" class=\"abstract_t\">30-32</a>].</p><p class=\"headingAnchor\" id=\"H3863617759\"><span class=\"h2\">Postpartum placental histology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postpartum histological findings show placental villi anchored directly on, or invading into or through, the myometrium, without an intervening decidual plate. The placenta is characterized as an accreta (<a href=\"image.htm?imageKey=OBGYN%2F60800\" class=\"graphic graphic_picture graphicRef60800 \">picture 1</a>), increta (<a href=\"image.htm?imageKey=OBGYN%2F73597\" class=\"graphic graphic_picture graphicRef73597 \">picture 2</a>), or percreta, depending on the greatest depth of myometrial invasion (superficial, deep, or penetrating the entire uterine wall), as the degree of villous adhesion or invasion is not always uniform [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/8\" class=\"abstract_t\">8</a>]. The diagnosis of focal accreta may be confirmed in the absence of hysterectomy by visualization of these findings in uterine curettings or in fragments of myometrium adherent to the placenta.</p><p>One group has developed a protocol for gross and microscopic pathologic examination of cases of suspected PAS, including correlation with clinical and radiologic findings [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/33\" class=\"abstract_t\">33</a>]. The standard, detailed examination can be helpful for postpartum discussions with patients and for research.</p><p class=\"headingAnchor\" id=\"H1042633652\"><span class=\"h1\">PRENATAL SCREENING AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prenatal screening and diagnosis are important so that the patient and her family can be counseled about the suspected placental abnormality and an appropriate site and plan for delivery can be developed. Preoperative preparation, including availability of surgical and radiological expertise, blood components for transfusion, and appropriate equipment, improves outcome. In two retrospective series, women with predelivery diagnosis of PAS had significantly lower blood loss and transfusion requirements than women in whom the condition was diagnosed during cesarean delivery [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/31,34\" class=\"abstract_t\">31,34</a>]. (See <a href=\"topic.htm?path=management-of-the-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">&quot;Management of the placenta accreta spectrum (placenta accreta, increta, and percreta)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3022736366\"><span class=\"h2\">Candidates and procedure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Women with a placenta previa or a low anterior placenta and prior uterine surgery should have thorough transabdominal and transvaginal sonographic evaluation of the interface between the placenta and myometrium between about 18 and 24 weeks of gestation. At this gestational age, the prenatal diagnosis of PAS can be made or ruled out with close to 90 percent accuracy, although in population-based studies prenatal diagnosis was not made in one-half to two-thirds of cases [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/35-37\" class=\"abstract_t\">35-37</a>]. Consistent use of a targeted screening protocol may be helpful [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/38\" class=\"abstract_t\">38</a>].</p><p>Ultrasound follow-up of patients with placenta previa or low anterior placenta is reviewed separately. (See <a href=\"topic.htm?path=placenta-previa-management#H4763313\" class=\"medical medical_review\">&quot;Placenta previa: Management&quot;, section on 'Monitoring placental position'</a>.)</p><p class=\"headingAnchor\" id=\"H1073084839\"><span class=\"h2\">Prenatal diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>PAS is highly likely in patients with placenta previa or a low lying placenta after one or more previous cesarean deliveries plus imaging studies suggestive of abnormal implantation, as described below (see <a href=\"#H3939740\" class=\"local\">'Ultrasound findings'</a> below). The diagnosis can be reasonably excluded when imaging studies suggest normal placental implantation. </p><p>Based on our experience with the management of hundreds of cases, we have found that placental lacunae (which appear as intraplacental sonolucent spaces) and disruption of the interface between the bladder wall-uterine serosa (bladder line) are the most reliable diagnostic sonographic findings. Color flow Doppler demonstrating turbulent (&quot;chaotic&quot;) flow <span class=\"nowrap\">and/or</span> bridging vessels are valuable confirmatory findings. If the ultrasound studies are inconclusive or ambiguous, magnetic resonance imaging (MRI) may be performed to clarify the diagnosis if this will affect patient management; however, the utility of the additional information gained by MRI is uncertain. (See <a href=\"#H3939740\" class=\"local\">'Ultrasound findings'</a> below and <a href=\"#H5133002\" class=\"local\">'Color Doppler'</a> below and <a href=\"#H3858442282\" class=\"local\">'Magnetic resonance imaging'</a> below.)</p><p class=\"headingAnchor\" id=\"H3939740\"><span class=\"h3\">Ultrasound findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the second and third trimesters, the following transabdominal and transvaginal sonographic findings have been associated with PAS; all of the findings need not be present [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/39-41\" class=\"abstract_t\">39-41</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Placental lacunae</strong> &ndash; Multiple large, irregular intraplacental sonolucent spaces (placental lacunae) in the center of a lobule or cotyledon adjacent to the involved myometrium replace normal placental homogeneity that give the placenta a &ldquo;moth-eaten&rdquo; appearance. In a meta-analysis, sensitivity of lacunae for identifying placenta accreta, increta, and percreta was about 75, 89, and 76 percent, respectively, and specificities were about 97, 98, and 99 percent, respectively [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/42\" class=\"abstract_t\">42</a>]. </p><p/><p class=\"bulletIndent1\">A normal placenta can have vascular lakes, typically a few small, sonolucent spaces with a regular shape and normal underlying myometrial thickness (<a href=\"image.htm?imageKey=OBGYN%2F117180\" class=\"graphic graphic_diagnosticimage graphicRef117180 \">image 1</a>). In contrast, the placental lacunae in PAS are more numerous, irregular in shape, and the underlying myometrium may be thinned (<a href=\"image.htm?imageKey=OBGYN%2F117181\" class=\"graphic graphic_diagnosticimage graphicRef117181 \">image 2</a>). Although a partial hydatidiform mole has a &quot;Swiss-cheese&rdquo;&quot; appearance (<a href=\"image.htm?imageKey=OBGYN%2F79947\" class=\"graphic graphic_diagnosticimage graphicRef79947 \">image 3</a>), the sonolucent spaces are small, distributed throughout the placenta, and have no blood flow.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Disruption of the bladder line </strong>&ndash; Loss or disruption of the normally continuous white line representing the bladder wall-uterine serosa interface (termed the &quot;bladder line&quot;) can be caused by placenta percreta or neovascularity related to placenta accreta or increta. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Loss of the clear zone</strong> &ndash; The normal hypoechoic area behind the placenta (termed the &quot;clear space&quot; or &quot;clear zone&quot;) (<a href=\"image.htm?imageKey=OBGYN%2F63825\" class=\"graphic graphic_diagnosticimage graphicRef63825 \">image 4</a>) may be missing or irregular. This sign can be obscured by direct pressure from the ultrasound probe and bladder filling [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/8\" class=\"abstract_t\">8</a>]. It can also be obscured with advancing gestational age and posterior placental location. </p><p/><p class=\"bulletIndent1\">In a meta-analysis, sensitivity of loss of the clear zone in identifying placenta accreta, increta, and percreta was about 75, 92, and 88 percent, respectively; specificity was about 92, 77, and 71 percent, respectively [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/42\" class=\"abstract_t\">42</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Myometrial thinning</strong> &ndash; The myometrium can be thin either due to a prior hysterotomy scar or due to placental invasion. When the placenta overlies the region of thinning, then it is important to look for other signs of PAS (<a href=\"image.htm?imageKey=RADIOL%2F83270\" class=\"graphic graphic_diagnosticimage graphicRef83270 \">image 5A</a>). For example, if the placenta is seen extending through the myometrium, then it is clearly an invasive placenta. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Abnormal vascularity </strong>&ndash; Vessels that extend from the placenta through the myometrium either into the bladder or through the serosa elsewhere are a clear sign of placenta percreta. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Placental bulge</strong> &ndash; A portion of the uterus attached to the abnormally adherent placenta can balloon into the bladder due to weakness of the underlying thin myometrium. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Exophytic mass</strong> &ndash; A focal mass that breaks through the uterine serosa, usually extending into the bladder, is a sign of placenta percreta.</p><p/><p>In one systematic review and meta-analysis of 20 studies of prenatal sonographic identification of placenta accreta, increta, and percreta, the sensitivity for depth of placental invasion was about 91, 93, 81 percent, respectively, and specificity was about 97, 98, and 99 percent, respectively [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/42\" class=\"abstract_t\">42</a>]. Foreknowledge of the clinical setting may have contributed to these results as performance was much lower (sensitivity 53 percent) in a study in which a diverse group of ultrasound providers were blinded to the patient's clinical status (eg, clinical suspicion for accreta, prior knowledge of risk factors) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/43\" class=\"abstract_t\">43</a>]. Also, histopathological correlation was not always performed or adequately described. Lastly, it is difficult to compare results of studies since nomenclature is not standardized and sonographic assessment of the depth of villous invasiveness in the uterine wall is subjective, without established ultrasound criteria for distinguishing between different grades of adherent and invasive placentation [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/44\" class=\"abstract_t\">44</a>]. Standardized terminology and criteria have been proposed by expert groups [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/45,46\" class=\"abstract_t\">45,46</a>].</p><p class=\"headingAnchor\" id=\"H5133002\"><span class=\"h4\">Color Doppler</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Color Doppler is useful for confirming the diagnosis of PAS when used in conjunction with the other ultrasound findings described above. Specific findings on color Doppler ultrasonography that suggest this diagnosis include (<a href=\"image.htm?imageKey=RADIOL%2F83270%7ERADIOL%2F97402\" class=\"graphic graphic_diagnosticimage graphicRef83270 graphicRef97402 \">image 5A-B</a>) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/47-49\" class=\"abstract_t\">47-49</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diffuse or focal intraparenchymal lacunar flow </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vascular lakes with turbulent flow</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypervascularity of serosa-bladder interface</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prominent subplacental venous complex</p><p/><p>Bridging vessels are color Doppler signals that arise in the myometrium and appear to travel into the bladder and then disappear. They are an ultrasound artifact rather than a true bridge into the bladder. They are seen in cross-sectional images of peritoneal neovascularity caused by dilation of large and deep subplacental myometrial vessels. </p><p>In the meta-analysis described above, lacunar flow had sensitivities of about 81, 84, and 45 percent for the detection of placenta accreta, increta, and percreta, respectively; specificity was about 84, 80, and 75 percent, respectively [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/42\" class=\"abstract_t\">42</a>]. Uterovesical hypervascularity for the detection of placenta accreta had low sensitivity (12 percent), but higher sensitivity for placenta increta (94 percent) and percreta (86 percent); specificity was 91, 88 and 88 percent, respectively. However, assessment of the performance of any individual sign is not clinically relevant since observation of one sign is likely to increase the chance of detecting others, and the signs are not evaluated in isolation.</p><p class=\"headingAnchor\" id=\"H3878483344\"><span class=\"h3\">Utility of additional imaging techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The role of the following imaging techniques in diagnosis of PAS has not been clearly determined.</p><p class=\"headingAnchor\" id=\"H3858442282\"><span class=\"h4\">Magnetic resonance imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>MRI may be more useful than ultrasound in two clinical scenarios: (1) evaluation of a possible posterior PAS because the bladder cannot be used to help clarify the placental-myometrial interface, and (2) assessment of the depth of myometrial and parametrial involvement, and, if the placenta is anterior, bladder involvement [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/50,51\" class=\"abstract_t\">50,51</a>]. However, increased accuracy beyond that noted with ultrasound is unproven. If performed, one group considers 24 to 30 weeks the ideal gestational age for imaging invasive placentation with MRI as false positives and negatives are more likely earlier and later in gestation [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/52\" class=\"abstract_t\">52</a>].</p><p>Magnetic resonance findings in placenta accreta include (<a href=\"image.htm?imageKey=OBGYN%2F81005%7EOBGYN%2F61154%7ERADIOL%2F97403\" class=\"graphic graphic_diagnosticimage graphicRef81005 graphicRef61154 graphicRef97403 \">image 6A-C</a>) [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/30,52-54\" class=\"abstract_t\">30,52-54</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Uterine bulging into the bladder</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Heterogeneous signal intensity within the placenta</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of intraplacental bands on the T2-W imaging</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormal placental vascularity </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Focal interruption of the myometrium</p><p/><p>Gadolinium, which may improve diagnostic performance [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/55\" class=\"abstract_t\">55</a>], is generally avoided in pregnancy. (See <a href=\"topic.htm?path=diagnostic-imaging-procedures-during-pregnancy#H26949515\" class=\"medical medical_review\">&quot;Diagnostic imaging procedures during pregnancy&quot;, section on 'Gadolinium'</a>.). </p><p>In a 2017 systematic review and meta-analysis of 20 studies totaling 1080 pregnancies with ultrasound suspicion or presence of clinical risk factors for PAS, MRI had high diagnostic accuracy: for detection of placenta accreta, increta, and percreta sensitivity was about 94, 100, and 87 percent, respectively; the corresponding values for specificity were about 99, 97, and 97 percent, respectively. [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/56\" class=\"abstract_t\">56</a>]. The accuracy of diagnosis with MRI is highly dependent on the expertise and experience of the radiologist interpreting the imaging study.</p><p class=\"headingAnchor\" id=\"H27505539\"><span class=\"h4\">Three-dimensional power Doppler ultrasound</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Three-dimensional (3D) ultrasound has been used successfully for evaluation of PAS [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/49,57\" class=\"abstract_t\">49,57</a>]. Diagnostic criteria include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Irregular intraplacental vascularization with tortuous confluent vessels crossing placental width</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypervascularity of uterine serosa-bladder wall interface</p><p/><p>In a study of 187 patients with placenta previa and a history of uterine surgery, 97 of 146 patients without confirmed PAS had none of the 5 two- or three-dimensional ultrasound findings associated with PAS and the remaining 49 patients had only 1 finding [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/57\" class=\"abstract_t\">57</a>]. By comparison, none of the 41 patients with PAS (placenta accreta or worse) had 0 or 1 of these findings; 5 had 2 findings and the remainder had 3 to 5 findings. </p><p>Another cohort study of 89 women noted 100 percent sensitivity with 92 percent specificity for three-dimensional power Doppler in the detection PAS [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/58\" class=\"abstract_t\">58</a>]. These findings are promising and should be assessed in larger populations to assess consistency and generalizability.</p><p class=\"headingAnchor\" id=\"H4204802564\"><span class=\"h4\">First trimester ultrasound examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The accuracy of first-trimester ultrasound examination for prenatal diagnosis of placental abnormality is unknown. PAS should be suspected if first-trimester ultrasound examination reveals a gestational sac in the lower uterine segment (rather than the fundus) next to or lower than the hysterotomy scar [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/59,60\" class=\"abstract_t\">59,60</a>] or a cesarean scar pregnancy. The characteristic second trimester findings of placental lacunae (which appear as intraplacental sonolucent spaces) and disruption of the interface between the bladder wall-uterine serosa (bladder line) also may be observed in the first trimester [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/61\" class=\"abstract_t\">61</a>]. Two separate reports suggested that a cesarean scar pregnancy is a precursor to PAS and that the diagnosis may be suspected either by a very thin (&lt;5 mm) anterior myometrial thickness [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/62\" class=\"abstract_t\">62</a>], or the location of the center of the gestational sac relative to the midpoint axis of the uterus [<a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/63\" class=\"abstract_t\">63</a>]. (See <a href=\"topic.htm?path=abdominal-pregnancy-cesarean-scar-pregnancy-and-heterotopic-pregnancy#H8\" class=\"medical medical_review\">&quot;Abdominal pregnancy, cesarean scar pregnancy, and heterotopic pregnancy&quot;, section on 'Cesarean scar pregnancy'</a>.) </p><p class=\"headingAnchor\" id=\"H15006693\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placenta accreta spectrum (PAS) is a general term comprising placenta accreta, increta, and percreta. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In placenta accreta, the anchoring villi attach to the myometrium; in placenta increta, the villi invade into the myometrium; and in placenta percreta, the villi penetrate to or through the uterine serosa and may invade surrounding organs. (See <a href=\"#H1822804338\" class=\"local\">'Definitions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>PAS is generally a consequence of defective decidualization in an area of scarring caused by previous uterine surgery. Because of the defective decidua, the placenta can attach directly to, and sometimes into or through, the myometrium. (See <a href=\"#H3937332\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most important risk factor for PAS is placenta previa after a prior cesarean delivery. PAS occurs in 11 percent of women with a placenta previa and one previous cesarean delivery. The risk increases substantially with increasing numbers of prior cesareans. Other risk factors, such as previous gynecologic procedures involving the uterus, should be considered, particularly among primigravidas. (See <a href=\"#H3937600\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women with a placenta previa or a low anterior placenta and prior uterine surgery should have thorough transabdominal and transvaginal sonographic evaluation of the interface between the placenta and myometrium between about 18 and 24 weeks of gestation. At this gestational age, the prenatal diagnosis of PAS can be made or ruled out with close to 90 percent accuracy. The diagnosis can be reasonably excluded when imaging studies suggest normal placental implantation. (See <a href=\"#H3022736366\" class=\"local\">'Candidates and procedure'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ideally, PAS is first suspected because of findings on obstetrical ultrasound examination while the patient is asymptomatic. The first clinical manifestation of PAS is either antenatal bleeding or profuse, life-threatening hemorrhage that occurs at the time of attempted manual placental separation. Part or all of the placenta remains strongly adherent to the uterine cavity, and no plane of separation can be developed. Accordingly, it is important to recognize the risk factors for PAS and attempt to make a prenatal diagnosis. (See <a href=\"#H3939541\" class=\"local\">'Clinical presentation'</a> above and <a href=\"#H15006491\" class=\"local\">'Consequences'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prenatal diagnosis of PAS is based upon the presence of characteristic findings on ultrasound examination, particularly in patients with placenta previa or a low lying placenta after one or more previous cesarean deliveries. We have found that placental lacunae (which appear as intraplacental sonolucent spaces (<a href=\"image.htm?imageKey=RADIOL%2F97402\" class=\"graphic graphic_diagnosticimage graphicRef97402 \">image 5B</a>)) and disruption of the interface between the bladder wall-uterine serosa (&quot;bladder line&quot;) are the most reliable sonographic diagnostic findings. In addition, the normal hypoechoic area behind the placenta (termed the &quot;clear space&quot; or &quot;clear zone&quot;) (<a href=\"image.htm?imageKey=OBGYN%2F63825\" class=\"graphic graphic_diagnosticimage graphicRef63825 \">image 4</a>) may be missing or irregular, and the retroplacental myometrium may be thin. </p><p/><p class=\"bulletIndent1\">Placenta percreta is suggested by ballooning of the retroplacental myometrium into the bladder, a retroplacental focal mass that breaks through the uterine serosa (especially if into the bladder), and vessels that extend from the placenta through the myometrium either into the bladder or through the serosa. Placenta percreta with bladder invasion can cause hematuria. </p><p/><p class=\"bulletIndent1\">Color flow Doppler demonstrating turbulent (&quot;chaotic&quot;) flow <span class=\"nowrap\">and/or</span> bridging vessels are valuable confirmatory findings of PAS. (See <a href=\"#H1073084839\" class=\"local\">'Prenatal diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Magnetic resonance imaging (MRI) is an adjunctive diagnostic tool when the diagnosis is uncertain, the placenta is posterior, or to gauge the extent of placental invasion if this will affect patient management. (See <a href=\"#H3858442282\" class=\"local\">'Magnetic resonance imaging'</a> above and <a href=\"#H1042633652\" class=\"local\">'Prenatal screening and diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/1\" class=\"nounderline abstract_t\">Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177:210.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/2\" class=\"nounderline abstract_t\">Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192:1458.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/3\" class=\"nounderline abstract_t\">Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980; 56:31.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/4\" class=\"nounderline abstract_t\">Mehrabadi A, Hutcheon JA, Liu S, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstet Gynecol 2015; 125:814.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/5\" class=\"nounderline abstract_t\">Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 2008; 29:639.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/6\" class=\"nounderline abstract_t\">Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008; 61:1243.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/7\" class=\"nounderline abstract_t\">Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta 2012; 33:244.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/8\" class=\"nounderline abstract_t\">Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and&nbsp;evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218:75.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/9\" class=\"nounderline abstract_t\">Ben-Nagi J, Walker A, Jurkovic D, et al. Effect of cesarean delivery on the endometrium. Int J Gynaecol Obstet 2009; 106:30.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/10\" class=\"nounderline abstract_t\">Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107:1226.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/11\" class=\"nounderline abstract_t\">Nageotte MP. Always be vigilant for placenta accreta. Am J Obstet Gynecol 2014; 211:87.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/12\" class=\"nounderline abstract_t\">Timor-Tritsch IE, Monteagudo A, Cali G, et al. Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound Obstet Gynecol 2014; 44:346.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/13\" class=\"nounderline abstract_t\">Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212:561.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/14\" class=\"nounderline abstract_t\">Kaser DJ, Melamed A, Bormann CL, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril 2015; 103:1176.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/15\" class=\"nounderline abstract_t\">Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012; 7:e52893.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/16\" class=\"nounderline abstract_t\">Hayashi M, Nakai A, Satoh S, Matsuda Y. Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used. Fertil Steril 2012; 98:922.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/17\" class=\"nounderline abstract_t\">Esh-Broder E, Ariel I, Abas-Bashir N, et al. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG 2011; 118:1084.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/18\" class=\"nounderline abstract_t\">Baldwin HJ, Patterson JA, Nippita TA, et al. Antecedents of Abnormally Invasive Placenta in Primiparous Women: Risk Associated With Gynecologic Procedures. Obstet Gynecol 2018; 131:227.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/19\" class=\"nounderline abstract_t\">Hung TH, Shau WY, Hsieh CC, et al. Risk factors for placenta accreta. Obstet Gynecol 1999; 93:545.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/20\" class=\"nounderline abstract_t\">Khong TY, Healy DL, McCloud PI. Pregnancies complicated by abnormally adherent placenta and sex ratio at birth. BMJ 1991; 302:625.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/21\" class=\"nounderline abstract_t\">James WH. Sex ratios of offspring and the causes of placental pathology. Hum Reprod 1995; 10:1403.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/22\" class=\"nounderline abstract_t\">Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993; 82:266.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/23\" class=\"nounderline abstract_t\">Zelop C, Nadel A, Frigoletto FD Jr, et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992; 80:693.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/24\" class=\"nounderline abstract_t\">Washecka R, Behling A. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. Hawaii Med J 2002; 61:66.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/25\" class=\"nounderline abstract_t\">Zelop CM, Harlow BL, Frigoletto FD Jr, et al. Emergency peripartum hysterectomy. Am J Obstet Gynecol 1993; 168:1443.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/26\" class=\"nounderline abstract_t\">Glaze S, Ekwalanga P, Roberts G, et al. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol 2008; 111:732.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/27\" class=\"nounderline abstract_t\">Gielchinsky Y, Mankuta D, Rojansky N, et al. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet Gynecol 2004; 104:527.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/28\" class=\"nounderline abstract_t\">Seet EL, Kay HH, Wu S, Terplan M. Placenta accreta: depth of invasion and neonatal outcomes. J Matern Fetal Neonatal Med 2012; 25:2042.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/29\" class=\"nounderline abstract_t\">O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996; 175:1632.</a></li><li class=\"breakAll\">Grosvenor, A, Silver, R, Porter, TF, Zempolich, K. Optimal Management of Placenta Accreta. Am J Obste Gynecol 2007; 195. Abstr No. 238. p. S82.</li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/31\" class=\"nounderline abstract_t\">Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010; 115:65.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/32\" class=\"nounderline abstract_t\">Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212:218.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/33\" class=\"nounderline abstract_t\">Dannheim K, Shainker SA, Hecht JL. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet 2016; 293:951.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/34\" class=\"nounderline abstract_t\">Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 2011; 90:1140.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/35\" class=\"nounderline abstract_t\">Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG 2014; 121:62.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/36\" class=\"nounderline abstract_t\">Bailit JL, Grobman WA, Rice MM, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125:683.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/37\" class=\"nounderline abstract_t\">Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016; 123:1348.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/38\" class=\"nounderline abstract_t\">Melcer Y, Jauniaux E, Maymon S, et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 2018.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/39\" class=\"nounderline abstract_t\">Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005; 26:89.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/40\" class=\"nounderline abstract_t\">Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992; 11:333.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/41\" class=\"nounderline abstract_t\">Guy GP, Peisner DB, Timor-Tritsch IE. Ultrasonographic evaluation of uteroplacental blood flow patterns of abnormally located and adherent placentas. Am J Obstet Gynecol 1990; 163:723.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/42\" class=\"nounderline abstract_t\">Pagani G, Cali G, Acharya G, et al. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97:25.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/43\" class=\"nounderline abstract_t\">Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014; 211:177.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/44\" class=\"nounderline abstract_t\">Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of&nbsp;prenatal ultrasound imaging and grading of&nbsp;villous invasiveness. Am J Obstet Gynecol 2016; 215:712.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/45\" class=\"nounderline abstract_t\">Bhide A, Sebire N, Abuhamad A, et al. Morbidly adherent placenta: the need for standardization. Ultrasound Obstet Gynecol 2017; 49:559.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/46\" class=\"nounderline abstract_t\">Collins SL, Ashcroft A, Braun T, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 2016; 47:271.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/47\" class=\"nounderline abstract_t\">Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000; 15:28.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/48\" class=\"nounderline abstract_t\">Twickler DM, Lucas MJ, Balis AB, et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000; 9:330.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/49\" class=\"nounderline abstract_t\">Shih JC, Palacios Jaraquemada JM, Su YN, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009; 33:193.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/50\" class=\"nounderline abstract_t\">Maldjian C, Adam R, Pelosi M, et al. MRI appearance of placenta percreta and placenta accreta. Magn Reson Imaging 1999; 17:965.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/51\" class=\"nounderline abstract_t\">Kirkinen P, Helin-Martikainen HL, Vanninen R, Partanen K. Placenta accreta: imaging by gray-scale and contrast-enhanced color Doppler sonography and magnetic resonance imaging. J Clin Ultrasound 1998; 26:90.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/52\" class=\"nounderline abstract_t\">Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, et al. MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. AJR Am J Roentgenol 2017; 208:214.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/53\" class=\"nounderline abstract_t\">Lax A, Prince MR, Mennitt KW, et al. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 2007; 25:87.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/54\" class=\"nounderline abstract_t\">Derman AY, Nikac V, Haberman S, et al. MRI of placenta accreta: a new imaging perspective. AJR Am J Roentgenol 2011; 197:1514.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/55\" class=\"nounderline abstract_t\">Millischer AE, Salomon LJ, Porcher R, et al. Magnetic resonance imaging for abnormally invasive placenta: the added value of intravenous gadolinium injection. BJOG 2017; 124:88.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/56\" class=\"nounderline abstract_t\">Familiari A, Liberati M, Lim P, et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/57\" class=\"nounderline abstract_t\">Cal&igrave; G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol 2013; 41:406.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/58\" class=\"nounderline abstract_t\">Collins SL, Stevenson GN, Al-Khan A, et al. Three-Dimensional Power Doppler Ultrasonography for Diagnosing Abnormally Invasive Placenta and Quantifying the Risk. Obstet Gynecol 2015; 126:645.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/59\" class=\"nounderline abstract_t\">Comstock CH, Lee W, Vettraino IM, Bronsteen RA. The early sonographic appearance of placenta accreta. J Ultrasound Med 2003; 22:19.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/60\" class=\"nounderline abstract_t\">Stirnemann JJ, Mousty E, Chalouhi G, et al. Screening for placenta accreta at 11-14 weeks of gestation. Am J Obstet Gynecol 2011; 205:547.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/61\" class=\"nounderline abstract_t\">Ballas J, Pretorius D, Hull AD, et al. Identifying sonographic markers for placenta accreta in the first trimester. J Ultrasound Med 2012; 31:1835.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/62\" class=\"nounderline abstract_t\">Rac MW, Moschos E, Wells CE, et al. Sonographic Findings of Morbidly Adherent Placenta in the First Trimester. J Ultrasound Med 2016; 35:263.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta/abstract/63\" class=\"nounderline abstract_t\">Timor-Tritsch IE, Monteagudo A, Cali G, et al. Easy sonographic differential diagnosis between intrauterine pregnancy and cesarean delivery scar pregnancy in the early first trimester. Am J Obstet Gynecol 2016; 215:225.e1.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6759 Version 41.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15006693\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H1822804338\" id=\"outline-link-H1822804338\">DEFINITIONS</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">INCIDENCE</a></li><li><a href=\"#H3937332\" id=\"outline-link-H3937332\">PATHOGENESIS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL FEATURES</a><ul><li><a href=\"#H3937600\" id=\"outline-link-H3937600\">Risk factors</a></li><li><a href=\"#H3939541\" id=\"outline-link-H3939541\">Clinical presentation</a></li><li><a href=\"#H260805669\" id=\"outline-link-H260805669\">Possible laboratory findings</a></li><li><a href=\"#H15006491\" id=\"outline-link-H15006491\">Consequences</a></li><li><a href=\"#H3863617759\" id=\"outline-link-H3863617759\">Postpartum placental histology</a></li></ul></li><li><a href=\"#H1042633652\" id=\"outline-link-H1042633652\">PRENATAL SCREENING AND DIAGNOSIS</a><ul><li><a href=\"#H3022736366\" id=\"outline-link-H3022736366\">Candidates and procedure</a></li><li><a href=\"#H1073084839\" id=\"outline-link-H1073084839\">Prenatal diagnosis</a><ul><li><a href=\"#H3939740\" id=\"outline-link-H3939740\">- Ultrasound findings</a><ul><li><a href=\"#H5133002\" id=\"outline-link-H5133002\">Color Doppler</a></li></ul></li><li><a href=\"#H3878483344\" id=\"outline-link-H3878483344\">- Utility of additional imaging techniques</a><ul><li><a href=\"#H3858442282\" id=\"outline-link-H3858442282\">Magnetic resonance imaging</a></li><li><a href=\"#H27505539\" id=\"outline-link-H27505539\">Three-dimensional power Doppler ultrasound</a></li><li><a href=\"#H4204802564\" id=\"outline-link-H4204802564\">First trimester ultrasound examination</a></li></ul></li></ul></li></ul></li><li><a href=\"#H15006693\" id=\"outline-link-H15006693\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"OBGYN/6759|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/117180\" class=\"graphic graphic_diagnosticimage\">- Single venous lake in normal placenta</a></li><li><a href=\"image.htm?imageKey=OBGYN/117181\" class=\"graphic graphic_diagnosticimage\">- Multiple, irregular placental lacunae in placenta accreta</a></li><li><a href=\"image.htm?imageKey=OBGYN/79947\" class=\"graphic graphic_diagnosticimage\">- Ultrasound partial hydatidiform mole</a></li><li><a href=\"image.htm?imageKey=OBGYN/63825\" class=\"graphic graphic_diagnosticimage\">- Sonogram of placenta previa and placenta previa accreta</a></li><li><a href=\"image.htm?imageKey=RADIOL/83270\" class=\"graphic graphic_diagnosticimage\">- Ultrasound and Doppler images of placenta accreta</a></li><li><a href=\"image.htm?imageKey=RADIOL/97402\" class=\"graphic graphic_diagnosticimage\">- Ultrasound of placental lacunae in placenta increta</a></li><li><a href=\"image.htm?imageKey=OBGYN/81005\" class=\"graphic graphic_diagnosticimage\">- MR normal placenta</a></li><li><a href=\"image.htm?imageKey=OBGYN/61154\" class=\"graphic graphic_diagnosticimage\">- MR placenta accreta</a></li><li><a href=\"image.htm?imageKey=RADIOL/97403\" class=\"graphic graphic_diagnosticimage\">- MRI of placenta increta</a></li></ul></li><li><div id=\"OBGYN/6759|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/60800\" class=\"graphic graphic_picture\">- Placenta accreta</a></li><li><a href=\"image.htm?imageKey=OBGYN/73597\" class=\"graphic graphic_picture\">- Placenta increta</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=abdominal-pregnancy-cesarean-scar-pregnancy-and-heterotopic-pregnancy\" class=\"medical medical_review\">Abdominal pregnancy, cesarean scar pregnancy, and heterotopic pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-imaging-procedures-during-pregnancy\" class=\"medical medical_review\">Diagnostic imaging procedures during pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-the-placenta-accreta-spectrum-placenta-accreta-increta-and-percreta\" class=\"medical medical_review\">Management of the placenta accreta spectrum (placenta accreta, increta, and percreta)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placenta-previa-management\" class=\"medical medical_review\">Placenta previa: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placental-development-and-physiology\" class=\"medical medical_review\">Placental development and physiology</a></li></ul></div></div>","javascript":null}